全文获取类型
收费全文 | 68227篇 |
免费 | 2860篇 |
国内免费 | 3038篇 |
专业分类
耳鼻咽喉 | 387篇 |
儿科学 | 1521篇 |
妇产科学 | 1591篇 |
基础医学 | 4985篇 |
口腔科学 | 2007篇 |
临床医学 | 6325篇 |
内科学 | 9899篇 |
皮肤病学 | 471篇 |
神经病学 | 1581篇 |
特种医学 | 3591篇 |
外科学 | 4669篇 |
综合类 | 14750篇 |
一般理论 | 9篇 |
预防医学 | 7586篇 |
眼科学 | 1253篇 |
药学 | 5090篇 |
4篇 | |
中国医学 | 5392篇 |
肿瘤学 | 3014篇 |
出版年
2023年 | 197篇 |
2022年 | 253篇 |
2021年 | 347篇 |
2020年 | 353篇 |
2019年 | 223篇 |
2018年 | 369篇 |
2017年 | 319篇 |
2016年 | 393篇 |
2015年 | 436篇 |
2014年 | 652篇 |
2013年 | 937篇 |
2012年 | 1563篇 |
2011年 | 4466篇 |
2010年 | 2645篇 |
2009年 | 1795篇 |
2008年 | 2273篇 |
2007年 | 2089篇 |
2006年 | 2173篇 |
2005年 | 3250篇 |
2004年 | 7923篇 |
2003年 | 7172篇 |
2002年 | 5639篇 |
2001年 | 4502篇 |
2000年 | 2732篇 |
1999年 | 3354篇 |
1998年 | 2395篇 |
1997年 | 2072篇 |
1996年 | 1320篇 |
1995年 | 1151篇 |
1994年 | 1239篇 |
1993年 | 1896篇 |
1992年 | 1618篇 |
1991年 | 1386篇 |
1990年 | 1085篇 |
1989年 | 866篇 |
1988年 | 634篇 |
1987年 | 537篇 |
1986年 | 517篇 |
1985年 | 248篇 |
1984年 | 131篇 |
1983年 | 77篇 |
1982年 | 64篇 |
1981年 | 61篇 |
1980年 | 46篇 |
1979年 | 65篇 |
1978年 | 44篇 |
1977年 | 56篇 |
1975年 | 58篇 |
1974年 | 47篇 |
1973年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
21.
22.
Bi-Hua BIE Yong CHEN Zhi-Qi ZHAO Institute of Neurobiology Fu-Dan University Shanghai China Institute of Shanghai Physiology Chinese Academy of Sciences Shanghai China 《中国神经科学杂志》2006,(2)
Objective Ligustrazine, also named as tetramethylpyrazine, is a compound purified from Ligusticum chuanxiong hort and has ever been testified to be a calcium antagonist. The present investigation was to determine the antinoci-ceptive effect of ligustrazine and, if any, the peripheral ionic mechanism involved. Methods Paw withdrawal Latency ( PWL) to noxious heating was measured in vivo and whole-cell patch recording was performed on small dorsal root ganglion (DRG) neurons. Results Intraplantar injection of ligustrazine (0.5 mg in 25μl) significantly prolonged the withdrawal latency of ipsilateral hindpaw to noxious heating in the rat. Ligustrazine not only reversibly inhibited high-voltage gated calcium current of dorsal root ganglion (DRG) neuron in dose-dependent manner with IC50 of 1.89 mmol/L, but also decreased tetrodotoxin (TTX) -resistant sodium current in relatively selective and dose-dependent manner with IC50 of 2.49 mmol/L. Conclusion The results suggested that ligustrazine could elevate the threshold of thermal nociception through inhibiting the high-voltage gated calcium current and TTX-resistant sodium current of DRG neuron in the rat. 相似文献
23.
24.
GIUSEPPE BORIANI MAURO BIFFI MAURIZIO RUSSO† MAURIZIO LUNATI‡ GIANLUCA BOTTO¶ ALESSANDRO PROCLEMER§ GIUSEPPE VERGARA WERNER RAHUE†† CRISTIAN MARTIGNANI RENATO RICCI† MASSIMO SANTINI† On Behalf of the SEARCH MI Registry Italian Investigators 《Pacing and clinical electrophysiology : PACE》2006,29(S2):S29-S34
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources. 相似文献
25.
26.
原北京医科大学(现为北京大学医学部)从20世纪90年代初开始,积极寻求与美国中华医学基金会的合作以促进医学伦理学的学科发展和国际化水平的提高。十几年来,北京大学医学部作为基地和依托极大地支持和引领了我国医学伦理学的教学改革与发展,增强了相关人员的医学伦理意识以及医学伦理学理论对实践的指导作用,促进了伦理学知识和能力的培训,提升了我国生物医学科研伦理的实力,奠定了医学伦理学继续教育的基础,使医学伦理学实现了系统性和跨越式的发展。 相似文献
27.
目的:观察并分析经皮穿刺气管切开术(PT)的急救效果。方法:从操作时间、术中出血、术后渗血、气道分泌物和切口愈合等五方面比较抢救成功的24例应用PT术和40例常规气管切开术患者的急救效果。结果:应用PT术呼吸道重建时间明显缩短,术中出血和术后渗血明显减少,伤口愈合明显加快,但对减少气道分泌物方面,与气管切开术无明显差异。结论:PT术安全可靠、简便省时,并发症少,可以明显提高急诊急救中呼吸道重建的效率。 相似文献
28.
29.
30.
含左氧氟沙星及卷曲霉素方案治疗耐多药肺结核近期疗效分析 总被引:21,自引:0,他引:21
目的 观察和评价含左氧氟沙星和卷曲霉素联合化疗方案在耐多药肺结核 (MDR PTB)治疗中的疗效。方法 将 177例MDR PTB患者分为治疗组 88例和对照组 89例。化疗方案 :治疗组以左氧氟沙星和卷曲霉素为主 ,联合利福喷汀、异烟肼、对氨基水杨酸钠、吡嗪酰胺 ;对照组用链霉素、乙胺丁醇 ,联用药物同治疗组 ,疗程均为 2 1个月。结果 共有 16 1例患者完成化疗疗程 ,治疗组 82例 ,痰菌阴转率 83% ;对照组 79例 ,痰菌阴转率 5 8% ;痰菌阴转率治疗组明显高于对照组 (P <0 0 1) ;治疗组病灶显效率 5 0 % ,空洞闭合率 6 3% ,治疗组优于对照组 (P <0 0 1) ;治疗组的药物不良反应率为 31% ,对照组为 35 % ,两组比较差异无显著性 (P >0 0 5 )。结论 含左氧氟沙星和卷曲霉素的方案治疗MDR PTB ,有助于痰菌阴转和病变吸收好转 ,药物不良反应低 ,值得在临床上推广应用 相似文献